CBIO
Crescent Biopharma, Inc.
14.30$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Crescent Biopharma, Inc. (CBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.7 | -7.6 | -11 | -8.9 | -8.0 | -3.7 | -11 | -16 | -18 | -27 | -8.9 | -19 | -73 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 35 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | |
| 0.9 | 0.9 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | 5.3 | 2.0 | 4.7 | 4.1 | 4.0 | 15 | |
| -0.6 | 0.3 | -1.2 | -0.2 | 0.2 | 2.4 | 3.1 | -2.2 | 5.0 | -19 | 10 | 3.0 | -1.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.6 | 72 | 8.1 | 0.0 | 81 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | -0.1 | -0.6 | -72 | -8.1 | 1.8 | -79 | |
| – | – | – | – | – | 0.0 | – | -0.2 | – | 0.2 | – | – | – | |
| – | – | – | – | – | 37 | – | – | – | – | – | – | – | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 41 | -1.5 | 147 | -1.3 | 179 | -6.9 | 0.1 | 171 | |
| -8.6 | -7.6 | -11 | -8.9 | -8.0 | -3.7 | -12 | 130 | -19 | 80 | -24 | -18 | 19 | |
| -8.7 | -7.6 | -11 | -8.9 | -8.0 | -3.7 | -11 | -17 | -18 | -99 | -17 | -19 | -154 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.